Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging is a PHASE2 clinical asset sponsored by Radboud University Medical Center in Oropharyngeal Squamous Cell Carcinoma. SEO and diligence focus: RGD PET/CT, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Oropharyngeal Squamous Cell Carcinoma
Modality: combination therapy
Target: RGD PET/CT
Sponsor: Radboud University Medical Center
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 28, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: RGD PET/CT
View original source fields
Condition raw: Oropharyngeal Squamous Cell Carcinoma
Condition normalized: Oropharyngeal Squamous Cell Carcinoma
Modality raw: combination therapy
Modality normalized: combination therapy
Target raw: RGD PET/CT
Target normalized: RGD PET/CT